A-29 - Health Insurance Act

Full text
22.1.0.1. To be entitled to remuneration by the Board, a pharmacist or, where applicable, an institution must indicate to the Board, on the statement of fees or claim for payment, that the contribution referred to in section 31 of the Act respecting prescription drug insurance (chapter A-29.01) has been collected.
The statement of fees or claim for payment must be submitted to the Board by the pharmacist or institution even if the entire cost of the insured services provided has been charged to that insured person in accordance with the Act respecting prescription drug insurance.
Before providing an insured service to an insured person, a pharmacist or institution must, to be entitled to remuneration by the Board, obtain prior authorization for payment from the Board by transmitting a statement of fees or claim for payment to the Board by interactive electronic means, in accordance with the terms and in the manner determined by the Board.
1992, c. 19, s. 5; 1996, c. 32, s. 95; 1999, c. 89, s. 42; 2007, c. 21, s. 26.
In the third paragraph, the words “or institution” will come into force on the date to be fixed by order of the Government (1996, c. 32, s. 119).
22.1.0.1. To be entitled to remuneration by the Board, a pharmacist or, where applicable, an institution must indicate to the Board, on the statement of fees or claim for payment, that the contribution referred to in section 31 of the Act respecting prescription drug insurance (chapter A‐29.01) has been collected.
The statement of fees or claim for payment must be submitted to the Board by the pharmacist or institution even if the entire cost of the insured services provided has been charged to that insured person in accordance with the Act respecting prescription drug insurance.
Before providing an insured service to an insured person, a pharmacist or institution must, to be entitled to remuneration by the Board, obtain prior authorization for payment from the Board by transmitting a statement of fees or claim for payment to the Board by interactive electronic means, in accordance with the conditions prescribed by regulation under section 16.1 of the Act respecting the Régie de l’assurance maladie du Québec (chapter R‐5).
1992, c. 19, s. 5; 1996, c. 32, s. 95; 1999, c. 89, s. 42.
In the third paragraph, the words “or institution” will come into force on the date to be fixed by order of the Government (1996, c. 32, s. 119).
22.1.0.1. To be entitled to remuneration by the Board, a pharmacist or, where applicable, an institution must indicate to the Board, on the statement of fees or claim for payment, that the contribution referred to in section 31 of the Act respecting prescription drug insurance (chapter A-29.01) has been collected.
The statement of fees or claim for payment must be submitted to the Board by the pharmacist or institution even if the entire cost of the insured services provided has been charged to that beneficiary in accordance with the Act respecting prescription drug insurance.
Before providing an insured service to a beneficiary, a pharmacist or institution must, to be entitled to remuneration by the Board, obtain prior authorization for payment from the Board by transmitting a statement of fees or claim for payment to the Board by interactive electronic means, in accordance with the conditions prescribed by regulation under section 16.1 of the Act respecting the Régie de l’assurance-maladie du Québec (chapter R-5).
1992, c. 19, s. 5; 1996, c. 32, s. 95.
In the third paragraph, the words “or institution” will come into force on the date to be fixed by order of the Government.
22.1.0.1. To be entitled to remuneration by the Board, a pharmacist must indicate to the Board, on his statement of fees or claim for payment, that he has collected the contribution referred to in section 14.3 or that a beneficiary has furnished him with a valid proof of exemption.
1992, c. 19, s. 5.